Evidence map›Paper›PMID 33158444›Full record

ArticleBMC biology2020

Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG.

Sofía Espinoza, Sebastián B Arredondo, Francisca Barake, Francisco Carvajal, Fernanda G Guerrero, Fabian Segovia-Miranda, David M Valenzuela, Ursula Wyneken, Alejandro Rojas-Fernández, Waldo Cerpa and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Sofía EspinozaCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, 7510157, Santiago, Chile.
Sebastián B ArredondoInstitute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andrés Bello, 8370146, Santiago, Chile.
Francisca BarakeCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, 7510157, Santiago, Chile.
Francisco CarvajalLaboratorio de Función y Patología Neuronal, Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8330028, Santiago, Chile.
Fernanda G GuerreroInstitute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andrés Bello, 8370146, Santiago, Chile.
Fabian Segovia-MirandaCentro de Envejecimiento y Regeneración (CARE), Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8330025, Santiago, Chile.
David M ValenzuelaRegeneron Pharmaceuticals, Inc., Tarrytown, 10591, NY, USA.
Ursula WynekenLaboratorio de Neurociencias, Facultad de Medicina, Universidad de los Andes, 7620001, Santiago, Chile.
Alejandro Rojas-FernándezCenter for Interdisciplinary Studies of the Nervous System (CISNe), Universidad Austral de Chile, 5090000, Valdivia, Chile.
Waldo CerpaCentro de Envejecimiento y Regeneración (CARE), Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, 8330025, Santiago, Chile.
Loreto MassardoCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, 7510157, Santiago, Chile.
Lorena Varela-NallarInstitute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andrés Bello, 8370146, Santiago, Chile.
Alfonso GonzálezCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, 7510157, Santiago, Chile. agonzara@uss.cl.ORCID 0000-0002-6139-4299
Pontificia Universidad Católica de Chile · CLUniversidad Andrés Bello · CLAustral University of Chile · CLRegeneron (United States) · USSan Sebastián University · CLUniversidad de Los Andes, Chile · CL

Funding

Training in noncommunicable diseases epidemiological, data science and Implementation Science research to strengthen evidence-based interventions, policy and control in Uganda.D43TW011401 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI Charles Batte, William Checkley · 2019 to 2026
$1.8M
Comisión Nacional de Investigación Científica y Tecnológica 21120650Comisión Nacional de Investigación Científica y Tecnológica 21120756Comisión Nacional de Investigación Científica y Tecnológica 21161392Comisión Nacional de Investigación Científica y Tecnológica 23190453Comisión Nacional de Investigación Científica y Tecnológica AFB170004Comisión Nacional de Investigación Científica y Tecnológica AFB170005Comisión Nacional de Investigación Científica y Tecnológica (CL) AFB170005Comisión Nacional de Investigación Científica y Tecnológica - Programa de Cooperación Internacional 20150065Fondef IdeA ID17I10037Fondo Nacional de Desarrollo Científico y Tecnológico 1140108Fondo Nacional de Desarrollo Científico y Tecnológico 1160513Fondo Nacional de Desarrollo Científico y Tecnológico 1190461Fondo Nacional de Desarrollo Científico y Tecnológico 1190620
6 · The paper itself

Abstract

backgroundCognitive dysfunction (CD) is common among patients with the autoimmune disease systemic lupus erythematosus (SLE). Anti-ribosomal P autoantibodies associate with this dysfunction and have neuropathogenic effects that are mediated by cross-reacting with neuronal surface P antigen (NSPA) protein. Elucidating the function of NSPA can then reveal CD pathogenic mechanisms and treatment opportunities. In the brain, NSPA somehow contributes to glutamatergic NMDA receptor (NMDAR) activity in synaptic plasticity and memory. Here we analyze the consequences of NSPA absence in KO mice considering its structural features shared with E3 ubiquitin ligases and the crucial role of ubiquitination in synaptic plasticity.

resultsElectrophysiological studies revealed a decreased long-term potentiation in CA3-CA1 and medial perforant pathway-dentate gyrus (MPP-DG) hippocampal circuits, reflecting glutamatergic synaptic plasticity impairment in NSPA-KO mice. The hippocampal dentate gyrus of these mice showed a lower number of Arc-positive cells indicative of decreased synaptic activity and also showed proliferation defects of neural progenitors underlying less adult neurogenesis. All this translates into poor spatial and recognition memory when NSPA is absent. A cell-based assay demonstrated ubiquitination of NSPA as a property of RBR-type E3 ligases, while biochemical analysis of synaptic regions disclosed the tyrosine phosphatase PTPMEG as a potential substrate. Mice lacking NSPA have increased levels of PTPMEG due to its reduced ubiquitination and proteasomal degradation, which correlated with lower levels of GluN2A and GluN2B NMDAR subunits only at postsynaptic densities (PSDs), indicating selective trafficking of these proteins out of PSDs. As both GluN2A and GluN2B interact with PTPMEG, tyrosine (Tyr) dephosphorylation likely drives their endocytic removal from the PSD. Actually, immunoblot analysis showed reduced phosphorylation of the GluN2B endocytic signal Tyr1472 in NSPA-KO mice.

conclusionsNSPA contributes to hippocampal plasticity and memory processes ensuring appropriate levels of adult neurogenesis and PSD-located NMDAR. PTPMEG qualifies as NSPA ubiquitination substrate that regulates Tyr phosphorylation-dependent NMDAR stability at PSDs. The NSPA/PTPMEG pathway emerges as a new regulator of glutamatergic transmission and plasticity and may provide mechanistic clues and therapeutic opportunities for anti-P-mediated pathogenicity in SLE, a still unmet need.

Indexed as

AnimalsAntigens, SurfaceMaleMiceNerve Tissue ProteinsNeuronal PlasticityNeuronsProtein Tyrosine Phosphatase, Non-Receptor Type 4Receptors, N-Methyl-D-AspartateUbiquitinationAntigens, SurfaceGprin1 protein, mouseNerve Tissue ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 4Receptors, N-Methyl-D-AspartateGluN2B Tyr1472MemoryNMDA receptorNPSLENSPAPostsynaptic densitiesSynaptic plasticityTyrosine phosphatase PTPMEG/PTPN4UbiquitinationZZEF1

Identifiers

PMID33158444
PMCPMC7648380
OpenAlexW3096819689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.